Contract 75N93021C00042
Via Therapeutics, Llc · Department Of Health And Human Services · September 3, 2021
Via Therapeutics, Llc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 3, 2021 for $300,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Austin, TX. It was awarded under a small business set-aside. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75N93021C00042
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Austin, TX
- First action
- September 3, 2021
Description
DEVELOPMENT OF LOW-COST, SHELF-STABLE, PATIENT- ADAPTABLE CLOFAZIMINE MINI-TABLETS FOR TREATMENT OF TUBERCULOSIS IN PEDIATRICS
Modification timeline
-
September 3, 2021Base award$300.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Battelle Memorial Institute | Department Of Health And Human Services | July 2, 2026 | $6.28M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | July 2, 2026 | $597.8K |
| Medigen, Inc. | Department Of Health And Human Services | July 2, 2026 | $2.18M |
| American Type Culture Collection | Department Of Health And Human Services | July 1, 2026 | $855.4K |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $11.71M |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $3.49M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93021C00042?
Contract 75N93021C00042 is a federal contract awarded to Via Therapeutics, Llc by Department Of Health And Human Services on September 3, 2021 for $300,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75N93021C00042?
Via Therapeutics, Llc won contract 75N93021C00042 from Department Of Health And Human Services.
How much is contract 75N93021C00042 worth?
Contract 75N93021C00042 has obligated $300,000 to date.